FDA Inspection 986751 — California Pharmacy & Compounding Center
The FDA completed an inspection of California Pharmacy & Compounding Center on August 31, 2016 in Newport Beach, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 31, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Newport Beach, CA (United States)